Spots Global Cancer Trial Database for map
Every month we try and update this database with for map cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera | NCT05269771 | Polycythemia Ve... | Ruxolitinib | 12 Years - 99 Years | Novartis | |
MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer | NCT05108740 | Advanced Hormon... | everolimus | 18 Years - 99 Years | Novartis | |
Managed Access Programs for PKC412, Midostaurin | NCT05219266 | FMS-Like Tyrosi... Acute Myeloid L... Aggressive Syst... Mast Cell Leuke... Systemic Mastoc... | midostaurin | 18 Years - | Novartis | |
MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer | NCT05108740 | Advanced Hormon... | everolimus | 18 Years - 99 Years | Novartis | |
Managed Access Programs for LDK378, Ceritinib | NCT05100134 | Anaplastic Lymp... Non-small Cell ... | ceritinib | 12 Years - | Novartis |